QPX7728

DRUG2 trials

Sponsors

Qpex Biopharma, Inc.

Conditions

Bacterial Infections

Phase 1

P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV

CompletedNCT04380207

Qpex Biopharma, Inc.Bacterial Infections

Start: 2020-11-24End: 2022-08-31Updated: 2022-10-10

Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects

CompletedNCT05072444

Qpex Biopharma, Inc.Bacterial Infections

Start: 2021-11-15End: 2021-11-23Updated: 2022-10-10